ArticleJournal of global health2025
Relationship between admission serum uric acid to lymphocyte ratio and the risk of ischemic stroke recurrence and death: a prospective study.
Article in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to explore the relationship between the Serum uric acid to lymphocyte ratio (ULR) level at admission and the long-term risk of recurrence and death in patients with acute ischemic stroke (AIS) in Liaoning Province. Methods: This multicentre prospective study enrolled 7966 subjects who experienced ischemic stroke (IS) across Liaoning Province, China. The Cox proportional hazards model and Kaplan-Meier curves were used to explore the association of ULR with the risk of recurrence and death in IS. Results: During a median follow-up period of 4.08 (3.35, 4.43) years, there were 1311 cases of stroke recurrence or death, 1429 cases of cardiovascular (CVD) death, and 910 cases of stroke-cause death. In analysis comparing the Q4 and Q1group, after multivariate adjustment, ULR was significantly positively associated with the incidence of stroke recurrence or death (Q4 vs. Q1: HR = 1.21; 95% CI = 1.04, 1.42), CVD death (Q4 vs. Q1: HR = 1.16; 95% CI = 1.00, 1.34), and stroke-cause death (Q4 vs. Q1: HR = 1.26; 95% CI = 1.05, 1.52). Additionally, the significant correlation between ULR and the risk of IS recurrence or death was partially mediated by diastolic blood pressure (DBP) (8.53%) and systolic blood pressure (SBP) (3.59%) in a positive manner. Conclusions: This study demonstrates that higher ULR is significantly associated with an increased risk of recurrence and death following IS. The findings suggest that ULR could serve as a valuable prognostic marker in clinical practice, particularly in managing patients with IS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.